Biomarker study reveals hidden long-term risks for TB patients
A new study led by PhD scholar Dr. Cheryl Kerama and researchers at the KAVI-Institute of Clinical Research has shed light on how tuberculosis (TB) may contribute to long-term metabolic and cardiovascular complications, even after successful treatment.